Bowman & CO S.C. Dexcom Inc Transaction History
Bowman & CO S.C.
- $220 Million
- Q2 2025
A detailed history of Bowman & CO S.C. transactions in Dexcom Inc stock. As of the latest transaction made, Bowman & CO S.C. holds 11,566 shares of DXCM stock, worth $912,094. This represents 0.46% of its overall portfolio holdings.
Number of Shares
11,566
Previous 7,054
63.96%
Holding current value
$912,094
Previous $481,000
109.77%
% of portfolio
0.46%
Previous 0.24%
Shares
6 transactions
Others Institutions Holding DXCM
# of Institutions
1,102Shares Held
370MCall Options Held
5.74MPut Options Held
4.85M-
Vanguard Group Inc Valley Forge, PA47.5MShares$3.74 Billion0.06% of portfolio
-
Black Rock Inc. New York, NY34.5MShares$2.72 Billion0.09% of portfolio
-
Baillie Gifford & CO16.7MShares$1.32 Billion1.14% of portfolio
-
State Street Corp Boston, MA16.7MShares$1.32 Billion0.05% of portfolio
-
Capital Research Global Investors Los Angeles, CA12MShares$949 Million0.19% of portfolio
About DEXCOM INC
- Ticker DXCM
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 386,257,984
- Market Cap $30.5B
- Description
- DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...